Carcinogenesis Advance Access published online on October 11, 2005
Carcinogenesis, doi:10.1093/carcin/bgi237
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Korean Hereditary Tumor Registry, Cancer Research Institute and Cancer Research Center, Seoul National University, Seoul, Korea
* To whom correspondence should be addressed. Various types of human cancers harbor BRAF somatic mutations, leading researchers to seek molecular targets for BRAF inhibitors. A mutually exclusive relationship has been observed between the BRAF V600E mutation and K-ras mutations, suggesting that the BRAF V600E mutation may differ from the other BRAF mutant types. Here, we used microarray analysis to examine differences between the BRAF and K-ras mutant colorectal samples and within the BRAF group (V600E versus non-V600E), in the hopes that the identified gene sets could form the basis for new target development. Eleven colorectal cancers with BRAF mutations and nine with K-ras mutations were examined by high-density microarray analysis. We also tested whether other significant genetic or clinical status involved in colorectal cancer development, such as APC and TP53 mutations, MSI, and TNM-Duke's staging, were related with the observed BRAF- or K-ras- associated expression profiles. Unsupervised two-way hierarchical clustering and multidimensional scaling revealed that the differentially expressed genes clustered according to the mutation status of BRAF and K-ras, and that samples with the BRAF V600E and non-V600E mutants could be distinguished from each other by gene profiling. Examination of TNM-Duke's staging, MSI and mutations in APC and TP53 revealed that these significant mutations could not account for the hierarchical clustering results observed in our study. We herein identified distinct gene expression patterns and gene sets that may form the basis for identification of BRAF-targeting molecules or provide researchers with a better understanding of the molecular pathogenesis underlying RAS-RAF signaling.
Received June 3, 2005
Revised August 15, 2005
Accepted September 28, 2005
CANCER BIOLOGY
Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations
2 Korean Hereditary Tumor Registry, Cancer Research Institute and Cancer Research Center, Seoul National University, Seoul, Korea; Research Institute and Hospital, National Cancer Center, 809 Madu-dong, Ilsan-gu, Goyang, Gyeonggi, 411-764, Korea
3 Department of Surgery, Seoul National University College of Medicine, Seoul, Korea
4 Korean Hereditary Tumor Registry, Cancer Research Institute and Cancer Research Center, Seoul National University, Seoul, Korea; Research Institute and Hospital, National Cancer Center, 809 Madu-dong, Ilsan-gu, Goyang, Gyeonggi, 411-764, Korea; Department of Surgery, Seoul National University College of Medicine, Seoul, Korea
Jae-Gahb Park, E-mail: park{at}ncc.re.kr
Abstract
5These authors (I-J.Kim and HC. Kang) contributed equally to this work.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. M. Talaat, S. K. Ward, C.-W. Wu, E. Rondon, C. Tavano, J. P. Bannantine, R. Lyons, and S. A. Johnston Mycobacterial Bacilli Are Metabolically Active during Chronic Tuberculosis in Murine Lungs: Insights from Genome-Wide Transcriptional Profiling J. Bacteriol., June 1, 2007; 189(11): 4265 - 4274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I.-J. Kim, H. C. Kang, S. G. Jang, S.-A Ahn, H.-J. Yoon, and J.-G. Park Development and Applications of a BRAF Oligonucleotide Microarray J. Mol. Diagn., February 1, 2007; 9(1): 55 - 63. [Abstract] [Full Text] [PDF]
|
|